Decades of dedication stand behind the European Medicines Agency. It is a key player in safeguarding public and animal health. The European Medicines Agency is located right here in Amsterdam.
The European Medicines Agency was established in 1995. It operates as a decentralised agency of the European Union. Its primary mission is to ensure that all medicines available in the EU are safe. They must also be effective and of high quality.
The European Medicines Agency plays a crucial role in the EU’s regulatory system for medicines. This system is one of the most advanced and comprehensive in the world. By harmonising the evaluation and supervision of medicines across the EU, the European Medicines Agency ensures that all EU citizens have access to medicines that meet the same high standards. This also facilitates the free movement of medicines within the single market. It significantly benefits the pharmaceutical industry and healthcare systems.
The European Medicines Agency’s core function is the scientific evaluation of applications for marketing authorization of medicines in the EU. This evaluation is carried out by the Committee for Medicinal Products for Human Use and the Committee for Medicinal Products for Veterinary Use. These committees assess the quality, safety, and efficacy of medicines before they can be authorized for use in the EU.
The European Medicines Agency plays a critical role in monitoring the safety of medicines. This happens throughout their lifecycle on the EU market. Through its pharmacovigilance activities, the European Medicines Agency evaluates new safety information. It can take action to protect public health. Actions can include updating product information or restricting the use of a medicine. In rare cases, a medicine can be withdrawn from the market.
The European Medicines Agency facilitates access to innovative medicines through various mechanisms. These include the accelerated assessment procedure. This can reduce the time to evaluate medicines of major public health interest. The Agency also provides scientific advice to pharmaceutical companies. This helps them prepare more robust marketing authorization applications.
Beyond evaluation and monitoring, the European Medicines Agency engages in activities aimed at promoting public health. This includes coordinating European and international efforts to combat antimicrobial resistance. It promotes the rational use of medicines. It supports research and development in the pharmaceutical sector.
The European Medicines Agency works closely with regulatory authorities around the world. This is to harmonize regulatory standards and practices. This facilitates global access to safe and effective medicines. This cooperation extends to sharing scientific expertise. It contributes to global health initiatives.
Emer Cooke is the Executive Director of the European Medicines Agency. The agency has a staff of 897.
The European Medicines Agency benefits patients, healthcare professionals, and academics. It also benefits pharmaceutical companies, medicine developers, and health policymakers. Through its scientific guidelines, scientific advice programme, and incentives, it facilitates research into new medicines and encourages development. This translates progress in medical science into medicines with real health benefits for patients. In particular, it promotes the development of medicines for children and drugs to tackle rare diseases.
The European Medicines Agency stands as a testament to international cooperation. It ensures the health and well-being of millions across Europe.